secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2025-02-21T23:59:59+00:00
Accession:  0001493152-25-007919
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics withdraws COVID-19 test 510(k) application; to submit enhanced version
--------------------------------------------------------------------------------

- Withdrew current 510(k) application for Co-Dx PCR COVID-19 Test after FDA feedback on component shelf-life stability.
- Plans to submit an enhanced version for OTC clearance after collecting new clinical evaluation data.
- Enhanced version to incorporate recent PCR platform developments to improve manufacturing efficiencies.
- Pipeline includes upcoming tests for tuberculosis, upper-respiratory multiplex, and HPV.
- No specific timeline provided for the new submission.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225007919/0001493152-25-007919-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225007919/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-007919

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer